Rectal Tumors
10
1
2
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
1 terminated out of 10 trials
85.7%
-0.8% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Effect of Dexmedetomidine on Lung Protection in Elderly Patients Undergoing Laparoscopic Surgery for Colorectal Cancer
Study of Daily Step Count and Treatment Response in Rectal Cancer (STEP-R)
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Peptide-based Immunization for Colon- and and Pancreas-carcinoma
Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Rectum Low Anterior Resection
Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy
Immunoscore in Rectal Cancer
Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial
Early Intervention for Erectile Dysfunction After Laparoscopic Resection for Rectal Cancer
Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery